Overview

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.
Phase:
Phase 2
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated